Confluent Medical Technologies announced today that it appointed Matthew Eckl as its new chief financial officer (CFO).
The Scottsdale, Arizona-based company made Eckl’s appointment effective today. His responsibilities include global financial strategy and financial operations. The company intends for Eckl to lead its accounting, financial planning and analysis, legal and information technology teams.
“We are thrilled to welcome Matt to Confluent,” said Dean Schauer, Confluent CEO. “Matt has exceptional experience in finance and financial operations as well as leadership across a variety of design and manufacturing organizations. As Confluent continues its significant growth, the addition of Matt to our company will further enhance the strength of our industry-leading team.”
Eckl previously served as CFO for five years at Dallas, Texas-based CECO Environmental. Before that, his experience included VP of finance for the energy group and global aftermarket division of Gardner Denver. He also held financial roles at GE.
“I am excited to join one of the medical device industry’s most trusted partners,” said Eckl. “Confluent’s ability to deliver world-class medical devices through its innovative material science, engineering, and manufacturing capabilities is truly remarkable. Confluent’s demonstrated focus on its mission, values, and culture was a key determinant in my decision to join its highly experienced management team.”